Aktuelle Innovationen

ERC PoC Förderung REVIVE an Sun Chong (2025)
ERC PoC Förderung TI-uORFe an Fabricio Loayza-Puch (2025)
HFSP Forschungsstipendium für den Berufseinstieg an Franziska Blaeschke (2025)
Emmy Noether Junior Gruppen Netzwerk an Lena Kutscher (2025)
Roche network Förderung imCORE an Mirco J. Friedrich (2025)
José Carreras Leukemia Foundation Förderung an Mirco J. Friedrich (2025)
DFG Weave EU Framework Förderung an Rene Jackstadt (2025)
Life and Health Alliance Heidelberg Mannheim Equipment Förderung an Sebastian Schölch (2025)
Life and Health Alliance Heidelberg Mannheim Förderung TACTICS an Moritz Mall (2025)
National Decades Against Cancer Konsortium DECIPHER-M an Priya Chudasama (2025)
DKFZ-MOST Deutsche-Israel Krebs Förderung Breaksome an Pei-Chi Wei (2025)
ERC Consolidator Förderung FusionTRACE an Ana Banito (2024)
ERC Consolidator Förderung Unstable Genome an Aurelie Ernst (2024) 

 

Erna-Brunner-Preis an Franziska Blaeschke (2025)
Hella Bühler Prize an Moritz Mall (2025)
Neuron Prize an Martina Benesova (2025)
EMBO Young Investigator Program an Ana Banito (2024)
EMBO Young Investigator Program an Aurelie Ernst (2024)
Kind-Philipp-Preis an Franziska Blaeschke (2024)
 

Clinical trail BilliCAN für Biliary Track Cancer intervention von Michael Dill (2025)
Clinical trail PERSIST-B7H6 für B cell malignancies von Mirco J. Friedrich (2025)
Clinical trail FLORA für HCC intervention von Michael Dill (2024)
Clinical trail TROPHIT1 phase II/III für Colorectal Cancer intervention von Rene Jackstadt (2024)
Clinical trail EXTRA für Colorectal Cancer registry von Rene Jackstadt (2024)
FDA Approval für Lu-177-PSMA-617 (Pluvicto®) von Martina Benesova (2024)
 

Lena Kutscher startet ihre Emmy-Noether-Nachwuchsgruppe ab 2025.
Aurelie Ernst ist seit 2025 Abteilungsleiterin.
Angela Gonçalves ist seit 2024 Professorin für Computational Prevention und Abteilungsleiterin.
Titus Brinker ist seit 2024 Abteilungsleiter.
 

Okonechnikov et al. showed Oncogene Aberrations Drive Medulloblastoma Progression. (2025) Nature
Lim et al. found PROX1 Restrains Cell Fate Plasticity in Liver. (2025) Nature Genetics
Xiao et al. demonstreated Radiation Sensitization by MEK and PARP Inhibitors. (2025) Cell Rep. Medicine
Egen et al. developed Hyperspectral Imaging Detects Renal Malperfusion. (2025) Eur. Urol. Open Sci.
Eickelschulte et al. performed Digital Spatial Profiling Reveals phospho-JNK Biomarker. (2025) Front. Oncology
Imle et al. Models High-Risk Sarcomas by Somatic Gene Delivery.  (2025) Nature Communications
Aviles-Huerta et al. found Dual Ribosome Profiling Reveals Tumor Metabolic Limits. (2025) Nature Communications
Kowar et al. found uORF Translation Boosts Tumor Antigen Presentation. (2025) Nature Communications
Hasegawa et al. found DNA Demethylating Agents Suppress Synovial Sarcoma. (2025) J. Clinical Investigation
Mahara et al. found Transient promoter interactions modulate gene activation, (2024) Molecular Cell
Corazzi and Ionasz et al. showed Replication Collision breaks DNA. (2024) Nature Communications 
Alhalabi et al. demonstrated WEE1 Targeting Enhances Dasatinib in Proneural GBM. (2024) Cancer Letters
Phillips et al. discovered Malformin C Sensitizes Glioblastoma Stem-Like Cells. (2024) Mol. Oncology
Baumgärtner et al. evaluated Medical Chatbot PROSCA for Patient Education. (2024) Eur. Urol. Open Sci.
Palazzo et al. defined a p53–eIF5A Axis Controls Senescence Surveillance (2024) Nature Communications